top of page
Search
    • Jan 11, 2016

New Alzheimer's Drug ANAVEX 2-73: A Phase 2a Study, Clinical Safety, and Tolerability

Alzheimer’s Association International Conference 2016, Toronto, Canada

Steve Macfarlane, Marco Cecchi, Dennis Moore, Paul Maruff, Kristina M. Capiak, Anastasios Zografidis, Christopher U. Missling


View Poster

bottom of page